title: TIF1γ-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody.
authors: Department of Dermatology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-Ku, Hamamatsu 431-3192, Japan. casuaki@hama-med.ac.jp.
authors: Akira
authors: A
authors: Kasuya
authors: Yasuhito
authors: Y
authors: Hamaguchi
authors: Manabu
authors: M
authors: Fujimoto
authors: Yoshiki
authors: Y
authors: Tokura
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood*; D002277:Carcinoma / Q000097:blood / Q000737:chemistry / Q000276:immunology* / Q000556:secondary / Q000601:surgery; D003882:Dermatomyositis / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D016889:Endometrial Neoplasms / Q000097:blood / Q000737:chemistry / Q000276:immunology* / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D011239:Prednisolone / Q000627:therapeutic use; D014157:Transcription Factors / Q000276:immunology*; D016896:Treatment Outcome; D015854:Up-Regulation
chemical_list: D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; C511956:TRIM33 protein, human; D014157:Transcription Factors; D011239:Prednisolone